Propranolol therapy for infantile haemangiomas: Review of the literature

International Journal of Pediatric Otorhinolaryngology

Volumn 74, Issue 4, 2010, Pages 338-342

  Zimmermann, A P ^a   Wiegand, S ^a   Werner, J A ^a   Eivazi, B ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Beta blocker; Haemangioma; Pharmacologic therapy; Propranolol

Indexed keywords

ACEBUTOLOL; BASIC FIBROBLAST GROWTH FACTOR; GELATINASE B; PREDNISOLONE; PROPRANOLOL; STEROID; VASCULOTROPIN; VINCRISTINE;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; BLEEDING; CAPILLARY ENDOTHELIUM; CARDIOVASCULAR DISEASE; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ENDOTHELIUM CELL; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEMANGIOMA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INFECTION; LETHARGY; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; RESTLESSNESS; REVIEW; SIDE EFFECT; SKIN DEFECT; STRIDOR; ULCER; VASOCONSTRICTION;

ADRENERGIC BETA-ANTAGONISTS; APOPTOSIS; DOWN-REGULATION; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTORS; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; MATRIX METALLOPROTEINASE 9; PROPRANOLOL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOCONSTRICTION;

EID: 77549084849     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2010.01.001     Document Type: Review

References (24)

1. Chang L.C., Haggstrom A.N., Drolet B.A., Baselga E., Chamlin S.L., Garzon M.C., et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122 (2008) 360-367
2. Léauté-Labrèze C., and Taieb A. Efficacy of beta-blockers in infantile haemangiomas: the physiopathological significance and therapeutic consequences. Ann. Dermatol. Venerol. 135 (2008) 860-862
3. Eivazi B., Ardelean M., Bäumler W., Berlien H.P., Cremer H., Elluru R., et al. Update on haemangiomas and vascular malformations of the head and neck. Eur. Arch. Otorhinolaryngol. 266 (2009) 187-197
4. Werner J.A., Dünne A.A., Lippert B.M., and Folz B.J. Optimal treatment of vascular birthmarks. Am. J. Clin. Dermatol. 4 (2003) 745-756
5. Buckmiller L., Dyamenahalli U., and Richter GT. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope (2009) (Epub ahead of print)
6. Nguyen J., and Fay A. Pharmacological therapy for periocular infantile haemangiomas: a review of the literature. Semin. Othalmol. 24 (2009) 178-184
7. Vlahovic A., Simic R., Djokic D., and Ceran C. Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report. J. Pediatr. Hematol. Oncol. 31 (2009) 858-860
8. Gottschling S., Schneider G., Meyer S., Reinhard H., Dill-Mueller D., and Graf N. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr. Blood Cancer 46 (2006) 239-242
9. Léauté-Labrèze C., Dumas de la Roque E., Hubiche T., Boralevi F., Thambo J.B., and Taieb A. Propranolol for severe haemangiomas of infancy. N. Engl. J. Med. 358 (2008) 2649-2651
10. Helfand M., Peterson K., and Dana T. Drug Class Review on Beta Adrenergic Blockers (2007). http://www.ohsu.edu/drugeffectiveness/reports/final.cfm
11. Siegfried E.C., Keenan W.J., and Al-Jureidini S. More on propranolol for haemangiomas of infancy. N. Engl. J. Med. 359 (2008) 2846-2847
12. Frazer K. Proceedings of the 67th Annual Meeting of the American Academy of Dermatology. San Francisco California, USA, 6-10 March (2009)
13. Frazer K. Am. J. Clin. Dermatol. 10 (2009) 205-210
14. Annabi B., Lachambre M.P., Plouffe K., Moumdjian R., and Béliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metallopteinase-9 secretion. Pharmacol. Res. (2009) (Epub ahead of print)
15. Cremer H.J., Kachel W., and Kosel C. Propranolol in der Behandlung problematischer Hämangiome (2009), Kinder- und Jugendarzt 40.Jg (Nr. 7)
16. Theletsane T., Redferjn A., Raynham O., Harris T., Prose N.S., and Khumalo N.P. Life-threatenting infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venerol (2009) (Epub ahead of print)
17. Itani M.H., and Fakih H. Response of facial haemangioma to oral propranolol. BMJ Case Rep. (2009)
18. Bigorre M., Van Kien A.K., and Valette H. Beta-blocking agent for treatment of infantile hemangioma. Plast. Reconstr. Surg. 123 (2009) 195e-196e
19. Denoyelle F., Leboulanger N., Enjolras O., Harris R., Roger G., and Garabedian E.N. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int. J. Pediatr. Otorhinolaryngol. 73 (2009) 1168-1173
20. Bonifazi E., Colonna V., Mazzotta F., Balducci G., and Laforgia N. Propranolol in rapidly growing hemangiomas. Eur. J. Pediatr. Dermatol. 18 (2008) 185-192
21. Sánchez Pérez R., Cortes Mora P., González Rodrígues J.D., Rodríguez Sánchez F., and De la Peña de Torres J. Treatment of infantile hemangioma with propranolol. Ann. Pediatr. (Barc.) July (2009) (Epub ahead of print)
22. Eivazi B., Teymoortash A., Stiller S., Cremer H.J., and Werner J.A. Betablockers-new perspektives for infantile hemangiomas of the head and neck. Laryngorhinootologie (2009) (Epub ahead of print)
23. Lawley L.P., Siegfried M.D., and Todd J.L. Propranolol treatment for haemangioma of infancy: risks and recommendations. Pediatr. Dermatol. 26 (2009) 610-614
24. Sans V., Dumas de la Roque E., Berge J., Grenier N., Boralevi F., Mazereeuw-Hautier J., et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 124 3 (2009)